Status:

COMPLETED

LiquiBand Versus Dermabond Versus Sutures for Closure of Surgical Wounds

Lead Sponsor:

Advanced Medical Solutions Ltd.

Conditions:

Surgical Incisions

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

To evaluate the cosmetic outcome, effectiveness, user and subject satisfaction, and safety of LiquiBand® Flex in relation to DermaBond Advanced™ and conventional sutures for the topical closure of sur...

Eligibility Criteria

Inclusion

  • Male or Female aged 18 or older on day of enrollment
  • Scheduled for surgical procedure by a delegated study surgeon
  • Fresh surgical wound with evenly distributed tension over length of incision
  • Willing and able to sign informed consent
  • Agree to return for 2 week (+/- 7 days) and 3 month (90 days +/- 7 days) post-procedure follow-up visit

Exclusion

  • Known sensitivity to cyanoacrylates, formaldehyde or acetone products
  • Wounds in which incision edges are under high tension or not easily apposed (after deep layer suture), or over joints (unless immobilized)
  • Wounds less than 15mm in length
  • Wounds in which haemostasis is not able to be achieved, eg, drain is placed or Warfarin level \>2.5 prior to surgery
  • Wounds in which deep closure could not be achieved
  • Surgical procedures involving mucus membranes or eyes
  • Mental incapacity, dementia, or inability to give informed consent
  • Pregnant or nursing
  • Disease related or pharmacologically immuno-compromised

Key Trial Info

Start Date :

February 20 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 14 2014

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT01835405

Start Date

February 20 2013

End Date

February 14 2014

Last Update

January 24 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Oncology Care Center, Beverly Hospital

Beverly, Massachusetts, United States, 01915